{"id":1303,"date":"2024-04-12T13:46:31","date_gmt":"2024-04-12T11:46:31","guid":{"rendered":"https:\/\/www.nuvr.cz\/?p=1303"},"modified":"2024-06-14T13:44:06","modified_gmt":"2024-06-14T11:44:06","slug":"new-ph-d-programmes-viewed-by-scientists-of-many-generations","status":"publish","type":"post","link":"https:\/\/www.nuvr.cz\/en\/2024\/04\/12\/new-ph-d-programmes-viewed-by-scientists-of-many-generations\/","title":{"rendered":"New Ph.D. Programmes Viewed by Scientists of Many Generations"},"content":{"rendered":"<p><b>We have asked your colleagues about their thoughts regarding the creation of two new interdisciplinary doctoral programmes, the Molecular and Translational Medicine at the Palack\u00fd University in Olomouc and Experimental and Clinical Oncology at the Charles University, two programmes created and operated under the auspices of the National Institute for Cancer Research.<\/b><\/p>\n<hr \/>\n<ol>\n<li>\n<h5><b>Do you believe it is a good idea to have molecular medicine represented in the portfolio of Ph.D. programmes?<\/b><\/h5>\n<\/li>\n<li>\n<h5><b>Where do you see the added value of bringing several areas of research into one doctoral programme?<\/b><\/h5>\n<\/li>\n<li>\n<h5><b>How do you perceive the role of \u2018clinicians\u2019 and \u2018non-clinicians\u2019 in biomedical research?<\/b><\/h5>\n<\/li>\n<\/ol>\n<hr \/>\n<h3><a class=\"https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/News_01_SCIGeneration_Bouchal_1-scaled-e1712822966870.jpg\" href=\"https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/News_01_SCIGeneration_Bouchal_1-scaled-e1712822966870.jpg\" rel=\"lightbox\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-1228 size-medium\" src=\"https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/News_01_SCIGeneration_Bouchal_1-scaled-e1713167667974-291x300.jpg\" alt=\"\" width=\"291\" height=\"300\" srcset=\"https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/News_01_SCIGeneration_Bouchal_1-scaled-e1713167667974-291x300.jpg 291w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/News_01_SCIGeneration_Bouchal_1-scaled-e1713167667974-995x1024.jpg 995w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/News_01_SCIGeneration_Bouchal_1-scaled-e1713167667974-768x791.jpg 768w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/News_01_SCIGeneration_Bouchal_1-scaled-e1713167667974-73x75.jpg 73w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/News_01_SCIGeneration_Bouchal_1-scaled-e1713167667974-480x494.jpg 480w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/04\/News_01_SCIGeneration_Bouchal_1-scaled-e1713167667974.jpg 1049w\" sizes=\"auto, (max-width:767px) 291px, 291px\" \/><\/a><a href=\"https:\/\/ubch.sci.muni.cz\/nas-vyzkum\/vyzkumne-skupiny\/proteomika\">Pavel Bouchal<\/a><\/h3>\n<p><b>Node Brno, Faculty of Science of the Masaryk University<br \/>\n<\/b><b>Primary focus: proteomics<\/b><\/p>\n<ol>\n<li><span style=\"font-weight: 400;\">Definitely, because modern management of cancers is crucially based on the molecular methods: for example, the analysis of mutations of gene panels for diagnosis and therapy prediction, or targeted therapy based on humanised antibodies or antibody-drug conjugates.<\/span><\/li>\n<li><span style=\"font-weight: 400;\"> In a current science, a qualified researcher must master not only many sophisticated laboratory methods and related data analysis approaches, but also understand the perspective of colleagues from other fields with whom he\/she participates in multidisciplinary collaboration. This is the principle of many outstanding studies in the field. Additionally, the researcher must be able to explain everything smoothly and flawlessly to the academic public from the position of the first or corresponding author of a resulting publication. A multidisciplinary Ph.D. programme is thus an ideal school for acquiring knowledge, establishing contacts, and to some extent it may also serve as a platform for a scientific collaboration.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Basically, one cannot work without the other. The \u2018clinician\u2019 is aware of limitations of current approaches in the clinics, while the \u2018non-clinician\u2019 has various molecular, cellular, and analytical methods in his\/her hands that can discover or suggest novel therapeutic options. If these two work in isolation, one without the other, there is a danger of getting them in stuck, each in his\/her own \u2018bubble\u2019, without any benefit to the patients. Like in daily life, though, there must be an interest of both to listen the other to reach understanding in science.<\/span><\/li>\n<\/ol>\n<h3><a href=\"https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/03\/News_01_SCIGeneration_Besse.webp\" rel=\"lightbox\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1258 size-medium alignright\" src=\"https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/03\/News_01_SCIGeneration_Besse-300x300.webp\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/03\/News_01_SCIGeneration_Besse-300x300.webp 300w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/03\/News_01_SCIGeneration_Besse-1024x1024.webp 1024w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/03\/News_01_SCIGeneration_Besse-150x150.webp 150w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/03\/News_01_SCIGeneration_Besse-768x768.webp 768w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/03\/News_01_SCIGeneration_Besse-1536x1536.webp 1536w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/03\/News_01_SCIGeneration_Besse-75x75.webp 75w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/03\/News_01_SCIGeneration_Besse-480x480.webp 480w, https:\/\/www.nuvr.cz\/wp-content\/uploads\/2024\/03\/News_01_SCIGeneration_Besse.webp 1707w\" sizes=\"auto, (max-width:767px) 300px, 300px\" \/><\/a><br \/>\n<a href=\"https:\/\/biology.med.muni.cz\/en\/research\/lenka-besse-group\/about\">Lenka Be\u0161\u0161e<\/a><\/h3>\n<p><b>Node Brno, Faculty of Medicine of the Masaryk University<br \/>\n<\/b><b>Primary focus: immunotherapy of tumours<\/b><\/p>\n<ol>\n<li><span style=\"font-weight: 400;\">Inclusion of molecular medicine into the portfolio of Ph.D. programmes is nowadays in high demand. Given the growing awareness of the genetic and molecular foundation of various diseases, it is important that future scientists have access to instruction and research in this area. What I perceive as positive are for instance the opportunities to study these subjects abroad: they can help us learn about the current questions that molecular medicine is trying to answer and thereby also the issues we should study in our laboratories.<\/span><\/li>\n<\/ol>\n<ol start=\"2\">\n<li><b><\/b><span style=\"font-weight: 400;\">The inclusion of several fields of research in one doctoral programme brings a number of advantages. Such programmes enable students to acquire a wider and interdisciplinary insight into the studied subject. It is nowadays quite clear that one person cannot be an expert in everything, but a broader awareness of a number of fields can help with addressing the right experts or with establishing interesting collaboration that can lead to innovative and exciting results.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">I find the presence of both clinicians and non-clinicians quite crucial. Clinicians, who work directly with patients, have a deeper understanding of their patients\u2019 clinical needs and of the challenges their patients face. They are in the best position to formulate the questions that should be addressed. The non-clinicians, on the other hand, have the tools and knowledge needed to provide answers to these questions. Their goal should be, among others, to find the mechanisms underlying those issues and ways of resolving or at least alleviating some of the problems. These possibilities can be subsequently moved into the clinics.<\/span><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>We have asked your colleagues about their thoughts regarding the creation of two new interdisciplinary doctoral programmes, the Molecular and Translational Medicine at the Palack\u00fd University in Olomouc and Experimental and Clinical Oncology at the Charles University, two programmes created and operated under the auspices of the National Institute for Cancer Research.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[77,78,82],"tags":[],"class_list":["post-1303","post","type-post","status-publish","format-standard","hentry","category-2024-1-en","category-newsletter-inscider-en","category-scigeneration-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/posts\/1303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/comments?post=1303"}],"version-history":[{"count":7,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/posts\/1303\/revisions"}],"predecessor-version":[{"id":2174,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/posts\/1303\/revisions\/2174"}],"wp:attachment":[{"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/media?parent=1303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/categories?post=1303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nuvr.cz\/en\/wp-json\/wp\/v2\/tags?post=1303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}